Search Results for "Merlion And Synthetic Biology"
Original Source: MerLion Pharmaceuticals Pte Ltd
MerLion Pharmaceuticals is a Singapore-based, privately held company, engaged in drug discovery from natural products. Its assets include one of the World's largest and most diverse natural product collections, proprietary purification technologies, high throughput screening (HTS) capabilities, proprietary IT database management systems and a highly experienced team. Our business focus is on discrete R & D collaborations with pharmaceutical companies, biotechs and other research organisations possessing nov...
Matching Channels
Matching News
MerLion's finafloxacin progresses for severe infections after positive IV results
Early clinical results with an intravenous formulation of MerLion Pharmaceuticals' finafloxacin indicate good potential for the use of the novel fluoroquinolone antibacterial in critical care setting...
Singapore’s MerLion Sees Positive Results For Phase I Intravenous Finafloxacin Trial
Singapore’s MerLion pushes ahead with its finafloxacin anti-bacterial candidate, successfully completing Phase I trials of an intravenous version.
Study: Synthetic biology research community has grown significantly
The number of private and public entities conducting research in synthetic biology worldwide grew significantly between 2009 and 2013, according to the latest version of an interactive map produced by...
The Synthetic Biology Pathway to Innovation in Fuels and Chemicals
Rob Carlson a principle at Biodesic, an engineering, consulting, and design firm in Seattle moderated a plenary session focused on synthetic biology at BIO’s Pacific Rim Summit on Industrial Bio...
Synthetic biology research community grows significantly
(Woodrow Wilson International Center for Scholars/Science and Technology Innovation Program) A new analysis by the Synthetic Biology Project finds the number of private and public entities conducting...
New report finds increase in media coverage of synthetic biology
(Woodrow Wilson International Center for Scholars/Science and Technology Innovation Program) Press coverage of synthetic biology in the United States and Europe increased significantly between 2008 an...
Can synthetic biology save wildlife?
What effects will the rapidly growing field of synthetic biology have on the conservation of nature? The ecological and ethical challenges stemming from this question will require a new dialogue betwe...
What’s more dangerous: Biology or synthetic biology?
Tom Knight got the bug for bioscience while he was a computer engineer at MIT. He founded the synthetic biology field and help set up bioengineering company Ginkgo BioWorks. He says we’ll soon be ab...
Matching PubMed Articles
Synthetic biology - the state of play.
Just over two years ago there was an article in Nature entitled "Five Hard Truths for Synthetic Biology". Since then, the field has moved on considerably. A number of economic commentators have shown...
Identification of aluminium dioxalate in fungal cultures grown on vermiculite.
Synthetic biology, inspired by synthetic chemistry.
The topic synthetic biology appears still as an 'empty basket to be filled'. However, there is already plenty of claims and visions, as well as convincing research strategies about the theme of synthe...
Approaches to chemical synthetic biology.
Synthetic biology is first represented in terms of two complementary aspects, the bio-engineering one, based on the genetic manipulation of extant microbial forms in order to obtain forms of life whic...
The one-day meeting on Synthetic DNA (January 24, 2012) organized by and held at the DECHEMA in Frankfurt attracted about 100 participants from academia and industry interested in synthesizing DNA and...
